Vida Ventures II, LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-07
4:20 pm
Sale
2025-03-0413DTectonic Therapeutic, Inc.
TECX
Vida Ventures II, LLC0
0.000%
-1,028,674decrease
(Position Closed)
Filing
History
2025-02-07
5:51 pm
Purchase
2025-02-0513DTectonic Therapeutic, Inc.
TECX
Vida Ventures II, LLC1,028,674
5.600%
1,028,674increase
(New Position)
Filing
History
2024-06-27
4:27 pm
Purchase
2024-06-2013DTectonic Therapeutic, Inc.
TECX
Vida Ventures II, LLC1,028,674
7.000%
1,028,674increase
(New Position)
Filing
History
2023-02-10
4:31 pm
Sale
2022-08-1513DDyne Therapeutics, Inc.
DYN
Vida Ventures II, LLC2,220,034
4.300%
-740,012decrease
(-25.00%)
Filing
History